1. Structural understanding of non-nucleoside inhibition in an elongating herpesvirus polymerase
- Author
-
Daniel J. Klein, Philip M. McKenna, Pravien Abeywickrema, Stephen M. Soisson, Edward M. Murray, Sujata Sharma, David M. Tellers, Kira A. Armacost, Mee Ra Heo, Christine Burlein, John C. Reid, Anthony W. Shaw, Izzat T. Raheem, Robert P Hayes, and Mark Mason
- Subjects
0301 basic medicine ,DNA polymerase ,viruses ,Science ,030106 microbiology ,General Physics and Astronomy ,DNA-Directed DNA Polymerase ,Virus Replication ,medicine.disease_cause ,Antiviral Agents ,Article ,General Biochemistry, Genetics and Molecular Biology ,Viral Proteins ,03 medical and health sciences ,chemistry.chemical_compound ,Drug Resistance, Viral ,medicine ,Herpes virus ,Nucleotide ,Herpesviridae ,Polymerase ,X-ray crystallography ,chemistry.chemical_classification ,Binding Sites ,Multidisciplinary ,biology ,Nucleotides ,General Chemistry ,Molecular biology ,Exodeoxyribonucleases ,030104 developmental biology ,Herpes simplex virus ,chemistry ,Coding strand ,Quinolines ,biology.protein ,Viral genome replication ,Nucleoside ,DNA - Abstract
All herpesviruses encode a conserved DNA polymerase that is required for viral genome replication and serves as an important therapeutic target. Currently available herpesvirus therapies include nucleoside and non-nucleoside inhibitors (NNI) that target the DNA-bound state of herpesvirus polymerase and block replication. Here we report the ternary complex crystal structure of Herpes Simplex Virus 1 DNA polymerase bound to DNA and a 4-oxo-dihydroquinoline NNI, PNU-183792 (PNU), at 3.5 Å resolution. PNU bound at the polymerase active site, displacing the template strand and inducing a conformational shift of the fingers domain into an open state. These results demonstrate that PNU inhibits replication by blocking association of dNTP and stalling the enzyme in a catalytically incompetent conformation, ultimately acting as a nucleotide competing inhibitor (NCI). Sequence conservation of the NCI binding pocket further explains broad-spectrum activity while a direct interaction between PNU and residue V823 rationalizes why mutations at this position result in loss of inhibition., Various herpesvirus therapeutics target the viral DNA polymerase. Here, the authors present the crystal structure of herpesvirus polymerase in the elongating state with bound primer-template DNA and the broad-spectrum non-nucleoside inhibitor PNU-183792, which is of interest for further drug design.
- Published
- 2021